Quality-of-life in interventionally treated patients with post-thrombotic syndrome

被引:20
作者
Catarinella, F. S. [1 ]
Nieman, F. H. M. [2 ]
de Wolf, M. A. F. [1 ]
Toonder, I. M. [1 ]
de Graaf, R. [3 ]
Wittens, C. H. A. [1 ,4 ]
机构
[1] Maastricht Univ, Med Ctr, Dept Venous Surg, NL-6200 MD Maastricht, Netherlands
[2] Maastricht Univ, Med Ctr, Clin Epidemiol & Med Technol Assessment, NL-6200 MD Maastricht, Netherlands
[3] Maastricht Univ, Med Ctr, Dept Radiol, NL-6200 MD Maastricht, Netherlands
[4] Univ Klinikum, Dept Vasc Surg, Aachen, Germany
关键词
Quality-of-life; post-thrombotic syndrome; deep venous obstruction; percutaneous transluminal angioplasty; venous stent; Maastricht University Medical Centre; Maastricht; DEEP-VEIN THROMBOSIS; OUTCOMES;
D O I
10.1177/0268355515569431
中图分类号
R61 [外科手术学];
学科分类号
摘要
Introduction New developments in the treatment of complex deep venous disease have become available in the last decade. Besides analysing patencies as a surrogate outcome for these treatments we analysed the Quality-of-Life (QoL) changes for successful and failed deep venous treatments. Materials and methods Patients with proven venous occlusive disease, referred to our department of Venous Surgery at the Maastricht University Medical Centre, were included. After inclusion patients were treated by percutaneous transluminal angioplasty and stenting and when indicated endophlebectomy with an arteriovenous fistula. QoL was assessed with the disease specific VEINES-QOL/Sym and the generic Short-Form (SF)-36 questionnaires preoperatively at baseline and post-operatively after 3, 12 and 24 months. Results One hundred fifty-three interventions were analysed, showing a primary, assisted primary and secondary patency of respectively 65%, 78% and 89% at 24 months. The VEINES-QOL and Sym scores improved at 3, 12 and 24 months. The overall improvement at 24 months is 22.7 for QoL and 18.18 for Sym with respective p values of 0.013 and 0.016. The improvement of the VEINES-QOL and Sym scores after a successful (patent) treatment remained highly significant (QoL: p<0.001, Sym: p=0.004). Also the generic QoL (Short-Form 36v2) shows significant improvement after 12 months for physical functioning (p=0.004) and role physical (p=0.004) scales. Conclusions The overall patencies of interventions for deep venous pathology are exceptionally good after two years. Concomitantly the VEINES-Sym and VEINES-QOL scores improve significantly for 3, 12, and 24 months when compared to the baseline (T0) after treatment. Successful interventions showed, as expected, a significant greater QoL improvement between T0 and T3, T12, T24 for both VEINES-QOL and VEINES-Sym scores when compared to the failed interventions. The one-year linear improvement of two SF-36 scales (PF and RP) is also significant.
引用
收藏
页码:89 / 94
页数:6
相关论文
共 50 条
  • [21] Levels of inflammatory markers and the development of the post-thrombotic syndrome
    Shbaklo, Hadia
    Holcroft, Christina A.
    Kahn, Susan R.
    THROMBOSIS AND HAEMOSTASIS, 2009, 101 (03) : 505 - 512
  • [22] Characterization of Post-Thrombotic Syndrome in Children with Cardiac Disease
    Manlhiot, Cedric
    McCrindle, Brian W.
    Williams, Suzan
    Menjak, Ines B.
    O'Shea, Sunita
    Chan, Anthony K.
    Brandao, Leonardo R.
    JOURNAL OF PEDIATRICS, 2019, 207 : 42 - 48
  • [23] Rivaroxaban versus warfarin for the prevention of post-thrombotic syndrome
    Utne, K. K.
    Dahm, A.
    Wik, H. S.
    Jelsness-Jorgensen, L. P.
    Sandset, P. M.
    Ghanima, W.
    THROMBOSIS RESEARCH, 2018, 163 : 6 - 11
  • [24] Biomarkers and the post-thrombotic syndrome: A systematic review of biomarkers associated with the occurrence of the post-thrombotic syndrome after lower extremity deep venous thrombosis
    Harbsmeier, Aksel Nathan
    Altintas, Izzet
    Iversen, Kasper
    Andersen, Ove
    Nehlin, Jan O.
    PHLEBOLOGY, 2023, 38 (09) : 577 - 598
  • [25] A cost analysis of the treatment of patients with post-thrombotic syndrome in Brazil
    Ramacciotti, Eduardo
    Gomes, Marise
    de Aguiar, Eduardo Toledo
    Caiafa, Jackson S.
    de Moura, Liberato Karaoglan
    Araujo, Gilson R.
    Truzzi, Ana
    Dietrich-Neto, Flavia
    THROMBOSIS RESEARCH, 2006, 118 (06) : 699 - 704
  • [26] Prevention of post-thrombotic syndrome
    不详
    INTERNATIONAL ANGIOLOGY, 2014, 33 (02) : 187 - 190
  • [27] PREVENTION OF POST-THROMBOTIC SYNDROME
    不详
    INTERNATIONAL ANGIOLOGY, 2013, 32 (02) : 243 - 246
  • [28] The post-thrombotic syndrome: A review
    Janssen, MCH
    Wollersheim, H
    vanAsten, WNJC
    deRooij, MJM
    Novakova, IRO
    Thien, T
    PHLEBOLOGY, 1996, 11 (03) : 86 - 94
  • [29] Biomarkers for post-thrombotic syndrome
    Bouman, Annemieke C.
    Atalay, Selma
    ten Cate, Hugo
    ten Wolde, Marije
    ten Cate-Hoek, Arina J.
    JOURNAL OF VASCULAR SURGERY-VENOUS AND LYMPHATIC DISORDERS, 2014, 2 (01) : 79 - +
  • [30] Prevention of post-thrombotic syndrome
    Daskalopoulos, M. M. E.
    PROCEEDINGS OF THE 20TH EUROCHAP EUROPEAN CHAPTER CONGRESS OF THE INTERNATIONAL UNION OF ANGIOLOGY - IUA, 2012, : 65 - 66